Viral Vectors, Engineered Cells and the CRISPR Revolution.

Area of Science:

• Biotechnology
• Genetics
• Medical Science

Background:

• Human cell editing has advanced significantly, impacting modern biology and medicine.
• Genome editing, gene delivery, and cell-based therapeutics are crucial for treating genetic diseases.
• CRISPR-Cas systems offer precision in correcting mutations in eukaryotic cells.

Purpose of the Study:

• To review progress in human cell editing using CRISPR-Cas systems.
• To highlight the use of viruses as vectors for gene therapy.
• To discuss the application of engineered cells in disease study and treatment.

Main Methods:

• Utilizing CRISPR-Cas systems for precise gene editing in human cells.
• Employing viral tropism for effective gene and gene editing system delivery.
• Engineering cells ex vivo for therapeutic and research applications.

Main Results:

• CRISPR-Cas systems enable precise correction of various disease mutations.
• Viral vectors are effective for delivering genetic payloads into cells.
• Ex vivo modified cells demonstrate significant potential in disease study and treatment.

Conclusions:

• Advances in human cell editing, gene therapy, and engineered cells are transforming clinical practice.
• CRISPR-Cas technology and viral delivery systems are key components of modern gene therapy.
• Engineered cells hold immense promise for future medical treatments and biological research.